Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores.
Aurelie MeunierAlexandra SoareHelene Chevrou-SeveracKarl-Johan MyrenTatsunori MurataLouise LongworthPublished in: Applied health economics and health policy (2021)
The developed mapping algorithms enable the prediction of EQ-5D-5L utilities from QLQ-C30 scores when EQ-5D-5L data have not been directly collected in clinical trials. The response mapping model offers the possibility of predicting EQ-5D-5L utility values using any national value set and can be generalised to multiple countries and oncology settings.